393 related articles for article (PubMed ID: 16465454)
1. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
Ceresoli-Borroni G; Rassoulpour A; Wu HQ; Guidetti P; Schwarcz R
J Neural Transm (Vienna); 2006 Oct; 113(10):1355-65. PubMed ID: 16465454
[TBL] [Abstract][Full Text] [Related]
2. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
[TBL] [Abstract][Full Text] [Related]
3. Endogenous kynurenic acid disrupts prepulse inhibition.
Erhardt S; Schwieler L; Emanuelsson C; Geyer M
Biol Psychiatry; 2004 Aug; 56(4):255-60. PubMed ID: 15312813
[TBL] [Abstract][Full Text] [Related]
4. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
5. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
7. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
[TBL] [Abstract][Full Text] [Related]
8. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
Okuno A; Fukuwatari T; Shibata K
J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
10. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
[TBL] [Abstract][Full Text] [Related]
11. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
[TBL] [Abstract][Full Text] [Related]
12. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.
Nilsson LK; Schwieler L; Engberg G; Linderholm KR; Erhardt S
Int J Neuropsychopharmacol; 2005 Sep; 8(3):329-39. PubMed ID: 15737250
[TBL] [Abstract][Full Text] [Related]
13. Acute Kynurenine Challenge Disrupts Sleep-Wake Architecture and Impairs Contextual Memory in Adult Rats.
Pocivavsek A; Baratta AM; Mong JA; Viechweg SS
Sleep; 2017 Nov; 40(11):. PubMed ID: 29029302
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on kynurenic acid production in the rat striatum by tryptophan enantiomers: an in vivo microdialysis study.
Ishii K; Iizuka H; Ogaya T; Song Z; Fukushima T
Chirality; 2011; 23 Suppl 1():E12-5. PubMed ID: 21433090
[TBL] [Abstract][Full Text] [Related]
15. Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.
Pocivavsek A; Wu HQ; Elmer GI; Bruno JP; Schwarcz R
Eur J Neurosci; 2012 May; 35(10):1605-12. PubMed ID: 22515201
[TBL] [Abstract][Full Text] [Related]
16. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections.
Ceresoli G; Guidetti P; Schwarcz R
Brain Res Dev Brain Res; 1997 May; 100(1):73-81. PubMed ID: 9174248
[TBL] [Abstract][Full Text] [Related]
18. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
[TBL] [Abstract][Full Text] [Related]
19. [New prospects for antipsychotic treatment - the role of the kynurenine pathway].
Karakuła-Juchnowicz H; Flis M; Szymona K; Kuczyńska M; Stelmach E; Kowal-Popczak A
Psychiatr Pol; 2014; 48(6):1167-77. PubMed ID: 25717486
[TBL] [Abstract][Full Text] [Related]
20. Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after D-kynurenine infusion: an in vivo microdialysis study.
Ogaya T; Song Z; Ishii K; Fukushima T
Neurochem Res; 2010 Apr; 35(4):559-63. PubMed ID: 19941066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
